VEGF165 promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition

Blood

Volumn 99, Issue 7, 2002, Pages 2532-2540

  Dias, Sergio ^a,b   Shmelkov, Sergey V ^a,b   Lam, George ^a,b   Rafii, Shahin ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELDANAMYCIN; HEAT SHOCK PROTEIN 90; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; VASCULOTROPIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION;

EID: 0036530301     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.7.2532     Document Type: Article

References (28)

1. Vascular endothelial growth factor (VEGF) and its receptors
2. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
3. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
4. Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes
5. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling
6. VPF/VEGF receptor-1 down-modulates VPFNEGF receptor-2 mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase dependent pathways
7. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
8. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
9. Heat-shock proteins inhibit induction of prostate cancer cell apoptosis
10. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome
11. Negative regulation of cytochrome c-mediated oligomerization of apaf-1 and activation of procaspase-9 by heat shock protein 90
12. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase
13. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase
14. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation
15. Regulation of transendothelial migration of hematopoietic progenitor cells
16. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias
17. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor
18. Prothymosin alpha
19. Relation of cell proliferation to expression of peripheral benzodiazepine receptors in human breast cancer cell lines
20. Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis
21. Hsp27 negatively regulates cell death by interacting with cytochrome c
22. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase
23. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
24. High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia
25. Human myeloid and lymphoid malignancies in the nonobese diabetic/severe combined immunodeficiency mouse model: Frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production
26. Angiogenesis and angiogenesis inhibition: An overview
27. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
28. Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis